Cubicin (Royalty rights)
M&A
STATUS
Buyout/LBO
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
A portfolio of royalty interests in an antibiotic drug. The portfolio comprises royalty rights in Cubicin, an antibiotic in a class of anti-infectives called lipopeptides.
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Other Business Products and Services
Acquirer
Primary Office
- United States
Cubicin (Royalty rights) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Cubicin (Royalty rights)‘s full profile, request access.
Request full access to PitchBook